EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Illustration of a heart with a monitor

Could gene therapy transform heart failure treatment?

A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.

Sanofi's chlamydia vaccine fast-tracked by FDA

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
Cartoon brain on green background

New study shines light on dementia in the workplace

A new study is challenging the belief that dementia is incompatible with modern work environments, with AI helping employees stay in work.

Pharma’s innovation ROI: Gains made, challenges ahead

The biopharmaceutical industry’s return on investment in innovation is increasing, but R&D costs are rising, according to a new Deloitte report.
British government buildings

VPAG hikes put UK life sciences at risk, warns pharma

The industry already contributes more than £17.6 billion directly to the UK economy, but it believes that growth has stagnated because of VPAG.

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.
Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.
We’ve noticed you’re accessing
from North/South America.